Post-Market Claims-Based Study of Serious Allergic Reactions and Eosinophilic Esophagitis in Marketed Use of RAGWITEK? in the United States (MK-3641-010) First published 13/01/2017 Last updated 03/08/2018 EU PAS number:EUPAS17248 Study Ongoing